Pharmacy

Your Article Summary

See Latest Articles

Cannabinoid receptor ligands as potential anticancer agents - high hopes for new therapies
Journal of Pharmacy and Pharmacology, 06/30/09

Oesch S et al. - The role of the endocannabinoid system in tumourigenesis is still poorly understood and the molecular mechanisms of cannabinoid anticancer action need to be elucidated. The development of CB2-selective anticancer agents could be advantageous in light of the unwanted central effects exerted by CB1 receptor ligands. Probably the most interesting question is whether cannabinoids could be useful in chemoprevention or in combination with established chemotherapeutic agents.

Today in Chemotherapy/Oncology...keeping you current

Receive free subspecialty "5-minute updates" via email

Valproic acid restores ERalpha and antiestrogen sensitivity to ERalpha-negative breast cancer cells
Molecular and Cellular Endocrinology, 11/25/09

N2 Disease in Patients With Head and Neck Squamous Cell Cancer Treated With Chemoradiotherapy
Archives of Otolaryngology, 11/25/09

Salvage treatment with upfront melphalan 100 mg/m2 and consolidation with novel drugs for fulminant progression of multiple myeloma
Annals of Hematology, 11/24/09

 See all of Chemotherapy/Oncology